We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+6.62%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$111B
AUM Growth
+$10.5B
(+10%)
Cap. Flow
+$4.07B
Cap. Flow
% of AUM
3.67%
Top 10 Holdings %
Top 10 Hldgs %
16.5%
Holding
4,333
New
263
Increased
1,254
Reduced
2,016
Closed
548
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$754M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$743M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$526M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$384M |
| 5 |
British American Tobacco
BTI
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$308M |
| 2 |
AGN
Allergan plc
AGN
|
+$233M |
| 3 |
BATS
Bats Global Markets, Inc.
BATS
|
+$190M |
| 4 |
ACAS
American Capital Ltd
ACAS
|
+$186M |
| 5 |
SLB Ltd
SLB
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.15% |
| 2 | Technology | 9.78% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 6.76% |
| 5 | Consumer Staples | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGNX
2476
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.45M | ﹤0.01% |
153,319
+72,706
| +90% | +$726K |
|
2477
Theravance Biopharma
TBPH
$874M
| $1.45M | ﹤0.01% |
39,246
-7,942
| -17% | -$254K |
|
2478
CALL
Viavi Solutions
VIAV
$9.12B
| $1.44M | ﹤0.01% |
+134,500
| New | +$1.31M |
|
2479
Atlanta Braves Holdings Series B
BATRK
$3.26B
| $1.44M | ﹤0.01% |
60,746
-25,363
| -29% | -$542K |
|
2480
Upbound Group
UPBD
$1.13B
| $1.43M | ﹤0.01% |
161,744
+8,035
| +5% | +$73.1K |
|
|
SONC
2481
DELISTED
Sonic Corp
SONC
| $1.43M | ﹤0.01% |
56,556
-30,181
| -35% | -$762K |
|
2482
Enanta Pharmaceuticals
ENTA
$366M
| $1.43M | ﹤0.01% |
46,458
+11,516
| +33% | +$359K |
|
|
CSGS
2483
DELISTED
CSG Systems International
CSGS
| $1.43M | ﹤0.01% |
37,810
-7,437
| -16% | -$315K |
|
2484
AZZ Inc
AZZ
$4.35B
| $1.43M | ﹤0.01% |
23,992
-7,447
| -24% | -$440K |
|
|
ESGR
2485
DELISTED
Enstar Group
ESGR
| $1.43M | ﹤0.01% |
7,469
-5,534
| -43% | -$1.07M |
|
2486
Acco Brands
ACCO
$389M
| $1.42M | ﹤0.01% |
108,309
-66,494
| -38% | -$864K |
|
|
RAVN
2487
DELISTED
Raven Industries Inc
RAVN
| $1.42M | ﹤0.01% |
48,964
-6,161
| -11% | -$167K |
|
2488
EXL Service
EXLS
$5.14B
| $1.42M | ﹤0.01% |
149,840
-71,690
| -32% | -$672K |
|
|
GES
2489
DELISTED
Guess Inc
GES
| $1.42M | ﹤0.01% |
127,206
-28,909
| -19% | -$356K |
|
2490
CALL
Eldorado Gold
EGO
$7.87B
| $1.41M | ﹤0.01% |
+82,960
| New | +$1.39M |
|
|
KND
2491
DELISTED
Kindred Healthcare
KND
| $1.41M | ﹤0.01% |
169,091
-4,723
| -3% | -$37K |
|
2492
KB Home
KBH
$3.37B
| $1.41M | ﹤0.01% |
70,792
-39,554
| -36% | -$692K |
|
|
KG
2493
Kestrel Group
KG
$69.4M
| $1.4M | ﹤0.01% |
5,012
-1,098
| -18% | -$361K |
|
|
HTLF
2494
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.4M | ﹤0.01% |
28,074
-2,481
| -8% | -$120K |
|
|
RMP
2495
DELISTED
Rice Midstream Partners LP
RMP
| $1.4M | ﹤0.01% |
55,640
-38,886
| -41% | -$955K |
|
2496
PUT
iShares MSCI Mexico ETF
EWW
$1.92B
| $1.4M | ﹤0.01% |
+27,400
| New | +$1.27M |
|
2497
Inogen
INGN
$175M
| $1.4M | ﹤0.01% |
18,062
-1,433
| -7% | -$99.3K |
|
|
STBZ
2498
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $1.4M | ﹤0.01% |
53,534
-7,365
| -12% | -$195K |
|
2499
Interface
TILE
$1.99B
| $1.4M | ﹤0.01% |
73,401
-11,932
| -14% | -$221K |
|
|
DM
2500
DELISTED
Dominion Energy Midstream Ptr LP
DM
| $1.4M | ﹤0.01% |
43,747
-1,022
| -2% | -$32K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2017 Portfolio in Review
As of Q1 2017, Credit Suisse held 4,333 positions worth $111B, up 10% from $100B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse deployed $4.07B of net new capital in Q1 2017, opening 263 new positions and adding to 1,254 existing holdings. Its largest new stake was Qiagen: 1,270,687 shares worth $39M.
By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Cognizant, an estimated $308M trimmed.
- Credit Suisse's largest Q1 2017 buy was Qiagen: 1,270,687 shares worth $39M.
- Credit Suisse added most to Reynolds American Inc in Q1 2017, an estimated $754M increase.
- Credit Suisse's biggest Q1 2017 reduction was Cognizant, cutting an estimated $308M.
- Credit Suisse fully exited Bats Global Markets, Inc. in Q1 2017, selling an estimated $190M.
- Credit Suisse's ten largest holdings make up 17% of its $111B portfolio in Q1 2017.
- Credit Suisse opened 263 new positions and closed 548 in Q1 2017.
- Credit Suisse's portfolio value rose 10% quarter-over-quarter to $111B.
Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.